Cell Therapy

Cigna Plans to Sell Medicare Business, WH Aims to Lower Sickle Cell Therapy Costs

February 7, 2024 - Cigna will sell its Medicare plans for billions of dollars, according to an announcement from HCSC. The independent licensee of Blue Cross Blue Shield Association revealed that it had plans to purchase Cigna's Medicare businesses--including but not limited to its Medicare Advantage and Part D plans--for $3.3 billion. The deal still has to jump...


More Articles

Top 2024 Predictions for the Life Sciences, Pharmaceutical Industries

by Kelsey Waddill

At the start of a new year, the life sciences and pharmaceutical industries face a roiling political climate, mental health crisis, and other challenges, but these industries are also riding a wave of...

Do Not Sell or Share My Personal Information
©2012-2024 TechTarget, Inc. Xtelligent Healthcare Media is a division of TechTarget. All rights reserved. HealthITAnalytics.com is published by Xtelligent Healthcare Media a division of TechTarget.